SHH:688578

Shanghai Allist Pharmaceuticals Co., Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:35 UTC

Last close

n/aCNY

Market data

18.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
34.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
42.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
0.001Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Price is the furthest below its sector's middle: 0.34 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Follow one yuan

lens 1 of 9

After what it costs to make

96.8%

After running the business

49.8%

After interest and tax

42.1%

After what it must reinvest

n/a

Kept after the dividend

n/a

after what it costs to make, 96.8% of sales; after running the business, 49.8% of sales; after interest and tax, 42.0% of sales

The five stops

3 of 5 read

After what it costs to make5,022,758,38096.8%
After running the business2,583,195,62349.8%
After interest and tax2,181,293,00042.1%
After what it must reinvestn/an/a
Kept after the dividendn/an/a

The last stop is empty on purpose. This filing does not tag a common dividend, so what is kept after it cannot be worked out. That is not the same fact as a company that paid no dividend, and we will not print a zero for it.

What is left after the dividend is not held for this company.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales5,187,338,133
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it costs to make5,022,758,380
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After running the business2,583,195,623
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After interest and tax2,181,293,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it must reinvestn/a
Not held.
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Kept after the dividendn/a
Not held.
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY